Page 265 - FINAL PROGRAMME 2017

P-497 Endometrial immunophenotype pro les in patients with adverse reproductive outcomes
C. Harrity1, J. Kennedy1, D. Walsh2, K. Marron3 1Sims International Fertility Clinic, Dublin, Ireland 2Sims IVF, Medical, Dublin, Ireland
3Sims IVF, Zentra Laboratories, Dublin, Ireland
P-498 Recurrent pregnancy loss evaluation combined with 23-chromosome testing of miscarriage tissue explains the cause of pregnancy loss in over 90% of all miscarriages
W.H. Kutteh1, F. Popescu2, R.W. Ke3, P.R. Brezina1, A. Bailey1, C.R. Jaslow2
1Vanderbilt University Medical Center, Obstetrics and Gynecolocy, Memphis- Tennessee, U.S.A. 2Rhodes College, Biology, Memphis- Tennessee, U.S.A.
3Vanderbilt University Medical Center, Obstetrics and Gynecolocy, Memphis- Tenessee, U.S.A.
FINAL PROGRAMME I GENEVA, SWITZERLAND – 2 TO 5 JULY 2017 265
POSTERS